Advancing Alzheimer’s Disease Research During COVID-19

Working at the cutting edge of AD research

Read more

Worldwide was founded in neuroscience, and we continue to innovate in our commitment to advancing research in Alzheimer’s disease, especially during COVID-19. Watch this video featuring Dr. Michael Murphy to learn more.


Chief Medical and Scientific Officer

Want to learn more about Worldwide Clinical Trials?